ORIC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.55%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $350,749.08

ORIC Pharmaceuticals Insider Trading History Chart

ORIC Pharmaceuticals Share Price & Price History

^$5.78

▲ +0.25 (4.52%)

As of 04/2/2025 05:00 PM ET

Days: 30 | 90 | 365

ORIC Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/16/2024	Dominic Piscitelli	CFO	Sell	8,851	$8.28	$73,286.28	106,764
12/16/2024	Jacob Chacko	CEO	Sell	24,660	$8.28	$204,184.80	778,648
12/16/2024	Pratik S Multani	Insider	Sell	8,850	$8.28	$73,278.00	46,765
2/6/2024	Jacob Chacko	CEO	Sell	13,958	$12.12	$169,170.96	794,586
12/15/2023	Jacob Chacko	CEO	Sell	14,539	$8.58	$124,744.62	808,544
12/15/2023	Pratik S Multani	Insider	Sell	5,282	$8.59	$45,372.38	23,809
7/10/2023	Jacob Chacko	CEO	Sell	10,508	$8.01	$84,169.08	785,808
7/5/2023	Jacob Chacko	CEO	Sell	4,336	$8.01	$34,731.36	796,316
6/26/2023	Jacob Chacko	CEO	Sell	20,000	$8.03	$160,600.00	800,652
12/15/2022	Jacob Chacko	CEO	Sell	5,764	$3.25	$18,733.00	817,025
12/15/2022	Pratik S Multani	Insider	Sell	2,089	$3.25	$6,789.25	7,423
5/13/2022	Jacob Chacko	CEO	Buy	76,072	$2.82	$214,523.04	802,652
5/11/2022	Jacob Chacko	CEO	Buy	304,574	$2.90	$883,264.60	657,226

See Full Table

SEC Filings (Institutional Ownership Changes) for ORIC Pharmaceuticals (NASDAQ:ORIC)

95.05% of ORIC Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ORIC Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	186,430	$1.50M	0.0%	+6.9%	0.262%
2/18/2025	Frazier Life Sciences Management L.P.	3,888,238	$31.38M	1.3%	-6.1%	5.510%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	35,579	$0.29M	0.0%	+54.5%	0.050%
2/17/2025	Two Sigma Advisers LP	66,500	$0.54M	0.0%	+14.3%	0.094%
2/17/2025	Two Sigma Investments LP	139,683	$1.13M	0.0%	-24.1%	0.198%
2/17/2025	Tema Etfs LLC	45,476	$0.37M	0.2%	N/A	0.064%
2/17/2025	Sphera Funds Management LTD.	273,213	$2.21M	0.4%	+112.8%	0.387%
2/17/2025	Rafferty Asset Management LLC	51,392	$0.42M	0.0%	-20.4%	0.073%
2/17/2025	ProShare Advisors LLC	20,683	$0.17M	0.0%	+30.9%	0.029%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	174,846	$1.41M	0.1%	+22.0%	0.248%
2/17/2025	NEA Management Company LLC	1,566,081	$12.64M	0.7%	+4.4%	2.219%
2/17/2025	Millennium Management LLC	27,634	$0.22M	0.0%	-90.6%	0.039%
2/17/2025	Janus Henderson Group PLC	14,600	$0.12M	0.0%	N/A	0.021%
2/17/2025	Deutsche Bank AG	57,437	$0.46M	0.0%	+48.4%	0.081%
2/17/2025	Cantor Fitzgerald L. P.	22,704	$0.18M	0.0%	N/A	0.032%
2/17/2025	Balyasny Asset Management L.P.	1,555,260	$12.55M	0.0%	+37.5%	2.204%
2/17/2025	Bank of America Corp DE	112,520	$0.91M	0.0%	+34.0%	0.159%
2/17/2025	BNP Paribas Financial Markets	8,801	$71K	0.0%	N/A	0.012%
2/17/2025	ArrowMark Colorado Holdings LLC	1,395,352	$11.26M	0.2%	+3.0%	1.977%
2/14/2025	Boxer Capital Management LLC	1,732,571	$13.98M	1.2%	N/A	2.455%
2/14/2025	Schonfeld Strategic Advisors LLC	724,319	$5.85M	0.0%	N/A	1.026%
2/14/2025	Northern Trust Corp	553,993	$4.47M	0.0%	+5.3%	0.785%
2/14/2025	Susquehanna Fundamental Investments LLC	20,275	$0.16M	0.0%	N/A	0.029%
2/14/2025	Virtus ETF Advisers LLC	8,434	$68K	0.0%	-29.7%	0.012%
2/14/2025	Voya Investment Management LLC	18,789	$0.15M	0.0%	-8.8%	0.027%
2/14/2025	Adage Capital Partners GP L.L.C.	500,000	$4.04M	0.0%	-13.0%	0.709%
2/14/2025	Price T Rowe Associates Inc. MD	1,295,025	$10.45M	0.0%	+16.2%	1.835%
2/14/2025	Silverarc Capital Management LLC	1,178,300	$9.51M	2.1%	+7.2%	1.670%
2/14/2025	Diadema Partners LP	214,291	$1.73M	0.7%	N/A	0.304%
2/14/2025	Tower Research Capital LLC TRC	14,661	$0.12M	0.0%	+1,048.1%	0.021%
2/14/2025	MetLife Investment Management LLC	41,608	$0.34M	0.0%	+15.3%	0.059%
2/14/2025	Natixis	79,900	$0.65M	0.0%	N/A	0.113%
2/14/2025	Dimensional Fund Advisors LP	717,188	$5.79M	0.0%	+16.8%	1.016%
2/13/2025	XTX Topco Ltd	25,966	$0.21M	0.0%	+120.9%	0.037%
2/13/2025	Barclays PLC	114,692	$0.93M	0.0%	+6.9%	0.163%
2/13/2025	Legal & General Group Plc	32,928	$0.27M	0.0%	-14.2%	0.047%
2/13/2025	Invesco Ltd.	23,958	$0.19M	0.0%	+8.5%	0.034%
2/13/2025	Wells Fargo & Company MN	35,857	$0.29M	0.0%	+30.2%	0.051%
2/12/2025	ExodusPoint Capital Management LP	23,417	$0.19M	0.0%	N/A	0.033%
2/12/2025	Geode Capital Management LLC	1,278,713	$10.32M	0.0%	+0.4%	1.812%
2/12/2025	Alliancebernstein L.P.	53,870	$0.44M	0.0%	-12.9%	0.076%
2/12/2025	Wellington Management Group LLP	186,430	$1.50M	0.0%	+6.9%	0.264%
2/12/2025	NEOS Investment Management LLC	45,476	$0.37M	0.0%	N/A	0.064%
2/12/2025	JPMorgan Chase & Co.	33,736	$0.27M	0.0%	-4.3%	0.048%
2/11/2025	Corebridge Financial Inc.	30,610	$0.25M	0.0%	-7.0%	0.043%
2/11/2025	Vanguard Group Inc.	3,203,789	$25.86M	0.0%	+1.2%	4.540%
2/11/2025	KLP Kapitalforvaltning AS	6,200	$50K	0.0%	N/A	0.009%
2/11/2025	American Century Companies Inc.	107,862	$0.87M	0.0%	+8.4%	0.153%
2/10/2025	Monaco Asset Management SAM	135,561	$1.09M	0.2%	-10.0%	0.192%
2/10/2025	Swiss National Bank	62,400	$0.50M	0.0%	+5.4%	0.088%
2/7/2025	AlphaQuest LLC	28,435	$0.23M	0.0%	+2,597.8%	0.040%
2/7/2025	PNC Financial Services Group Inc.	13,517	$0.11M	0.0%	+22.9%	0.019%
2/6/2025	M&T Bank Corp	99,234	$0.80M	0.0%	+16.6%	0.141%
2/6/2025	Victory Capital Management Inc.	97,500	$0.79M	0.0%	-2.3%	0.138%
2/6/2025	Charles Schwab Investment Management Inc.	417,955	$3.37M	0.0%	+1.9%	0.592%
1/30/2025	Rhumbline Advisers	93,319	$0.75M	0.0%	+4.6%	0.132%
1/24/2025	China Universal Asset Management Co. Ltd.	14,963	$0.12M	0.0%	+10.3%	0.021%
1/17/2025	SG Americas Securities LLC	66,364	$0.54M	0.0%	-4.7%	0.094%
1/15/2025	Hennion & Walsh Asset Management Inc.	162,909	$1.32M	0.1%	+18.1%	0.231%
12/26/2024	JPMorgan Chase & Co.	35,251	$0.36M	0.0%	+3.8%	0.050%
11/27/2024	Franklin Resources Inc.	950,459	$9.07M	0.0%	+26.1%	1.347%
11/19/2024	Barclays PLC	107,261	$1.10M	0.0%	+111.2%	0.152%
11/16/2024	Geode Capital Management LLC	1,273,513	$13.06M	0.0%	+4.2%	1.805%
11/15/2024	M&T Bank Corp	85,137	$0.87M	0.0%	+19.2%	0.121%
11/15/2024	Barclays PLC	107,261	$1.10M	0.0%	+111.2%	0.152%
11/15/2024	XTX Topco Ltd	11,757	$0.12M	0.0%	-45.7%	0.017%
11/15/2024	Jane Street Group LLC	47,849	$0.49M	0.0%	-53.4%	0.068%
11/15/2024	Wellington Management Group LLP	174,388	$1.79M	0.0%	+42.0%	0.247%
11/15/2024	Sphera Funds Management LTD.	128,396	$1.32M	0.2%	N/A	0.182%
11/15/2024	State Street Corp	1,938,169	$19.87M	0.0%	-14.1%	2.747%
11/15/2024	ArrowMark Colorado Holdings LLC	1,354,508	$13.88M	0.2%	+6.4%	1.919%
11/14/2024	Fred Alger Management LLC	219,447	$2.25M	0.0%	+40.8%	0.311%
11/14/2024	Verition Fund Management LLC	42,980	$0.44M	0.0%	+25.6%	0.061%
11/14/2024	Alkeon Capital Management LLC	3,904,096	$40.02M	0.1%	+2.6%	5.535%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	23,034	$0.24M	0.0%	-45.6%	0.033%
11/13/2024	FMR LLC	4,378,819	$44.88M	0.0%	-11.0%	6.208%
11/12/2024	Charles Schwab Investment Management Inc.	410,229	$4.21M	0.0%	+152.7%	0.582%
11/9/2024	Intech Investment Management LLC	19,468	$0.20M	0.0%	N/A	0.028%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	12,832	$0.13M	0.0%	N/A	0.018%
11/7/2024	First Turn Management LLC	1,451,037	$14.87M	2.4%	-4.3%	2.057%
11/6/2024	Cornercap Investment Counsel Inc.	10,063	$0.10M	0.0%	-53.7%	0.014%
11/5/2024	Victory Capital Management Inc.	99,750	$1.02M	0.0%	+4.1%	0.141%
10/25/2024	China Universal Asset Management Co. Ltd.	13,568	$0.14M	0.0%	+71.3%	0.019%
10/23/2024	Hennion & Walsh Asset Management Inc.	137,962	$1.41M	0.1%	+34.7%	0.196%
10/11/2024	Creative Planning	11,272	$0.12M	0.0%	N/A	0.016%
10/3/2024	SG Americas Securities LLC	69,620	$0.71M	0.0%	N/A	0.099%
8/15/2024	The Manufacturers Life Insurance Company	131,350	$0.93M	0.0%	+7.7%	0.195%
8/15/2024	Millennium Management LLC	782,299	$5.53M	0.0%	+297.4%	1.160%
8/15/2024	AQR Capital Management LLC	12,241	$87K	0.0%	-14.4%	0.018%
8/14/2024	Squarepoint Ops LLC	33,984	$0.24M	0.0%	+95.6%	0.050%
8/14/2024	Fred Alger Management LLC	155,912	$1.10M	0.0%	-29.1%	0.231%
8/14/2024	Profund Advisors LLC	21,861	$0.16M	0.0%	+23.6%	0.032%
8/12/2024	XTX Topco Ltd	21,638	$0.15M	0.0%	N/A	0.032%
8/9/2024	Renaissance Technologies LLC	47,000	$0.33M	0.0%	-57.6%	0.070%
8/9/2024	Dimensional Fund Advisors LP	466,662	$3.30M	0.0%	+190.2%	0.692%
8/8/2024	First Turn Management LLC	1,515,960	$10.72M	1.7%	+38.1%	2.248%
8/8/2024	Cornercap Investment Counsel Inc.	21,738	$0.15M	0.0%	N/A	0.032%
8/8/2024	American Century Companies Inc.	84,201	$0.60M	0.0%	+15.1%	0.125%
8/7/2024	Monaco Asset Management SAM	301,650	$2.13M	0.3%	+132.0%	0.447%
8/6/2024	Quest Partners LLC	10,378	$73K	0.0%	+253.2%	0.015%

Data available starting January 2016

See Full Table

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, which is designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study; and ORIC-533, an orally bioavailable small molecule inhibitor of CD73, currently under Phase 1b study, being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms, including ORIC-613, an orally bioavailable, highly selective inhibitor of PLK4, in preclinical studies for the treatment of breast cancers. It has a license and collaboration agreement with Voronoi Inc.; a license agreement with Mirati Therapeutics, Inc.; and clinical development collaboration agreement with Pfizer Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

Today's Range

Now: $5.78

$5.32

$5.98

50 Day Range

MA: $8.57

$5.53

$12.54

52 Week Range

Now: $5.78

$5.25

$14.67

Volume

647,091 shs

Average Volume

615,699 shs

Market Capitalization

$410.54 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.25

Who are the company insiders with the largest holdings of ORIC Pharmaceuticals?: ORIC Pharmaceuticals' top insider shareholders include:
Jacob Chacko (CEO)
Dominic Piscitelli (CFO)
Pratik S Multani (Insider)
Learn More about top insider investors at ORIC Pharmaceuticals.